Product Information
DABIGATRAN ETEXILATE 75 MG CAP is a generic product labeled by Ascend Laboratories, LLC, priced at $0.8430 per EA under NDC 67877047460. Its NADAC has been published 179 times since Mar 22, 2023.
FDA first approved this application on Mar 11, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
75 mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877047460
Classification
Generic
Dosage Form
CAPSULE, COATED PELLETS
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
DABIGATRAN ETEXILATE MESYLATEApproval Type
Generic (ANDA)
FDA Application
ANDA208040FDA Approved
3/11/2020
TE Code
AB
On Market Since
6/20/2022
Pharmacological Classes
Price Statistics
The NADAC for DABIGATRAN ETEXILATE 75 MG CAP has been published 179 times since Mar 22, 2023, and over the history we have for it it has declined 86.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8430 per EA |
|---|---|
| All-time high | $6.3586 (Apr 10, 2024) |
| All-time low | $0.8430 (Aug 19, 2026) |
| 52-week high | $1.1670 |
| 52-week low | $0.8430 |
| Median price | $2.0530 |
| Average price | $3.0497 |
| Largest weekly change | -58.2% (Apr 17, 2024) |
| Weeks tracked | 179 |
| Tracking since | Mar 22, 2023 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DABIGATRAN ETEXILATE 75 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for DABIGATRAN ETEXILATE 75 MG CAP, manufactured by Ascend Laboratories, LLC, is $0.8430 per EA (NDC 67877047460), effective Aug 19, 2026.
How has the price of DABIGATRAN ETEXILATE 75 MG CAP changed over time?
Over the history we have for it, the NADAC for DABIGATRAN ETEXILATE 75 MG CAP has declined 86.2%. It has been tracked across 179 weekly CMS publications since Mar 22, 2023.
What are the highest and lowest recorded NADAC prices for DABIGATRAN ETEXILATE 75 MG CAP?
Since Mar 22, 2023, the NADAC for DABIGATRAN ETEXILATE 75 MG CAP has ranged from a low of $0.8430 (Aug 19, 2026) to a high of $6.3586 (Apr 10, 2024), with a median of $2.0530 per EA.
Are there cheaper alternatives to DABIGATRAN ETEXILATE 75 MG CAP?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DABIGATRAN ETEXILATE 75 MG CAP in a comparable dosage form, but none are currently priced below it.
Who manufactures DABIGATRAN ETEXILATE 75 MG CAP?
DABIGATRAN ETEXILATE 75 MG CAP (NDC 67877047460) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.